SCHEMBL30439175

SCHEMBL30439175

CCC1CN(C(=O)OC(C)(C)C)CCCN1S(=O)(=O)c1cccc2c(OC)nccc12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 3/20 0.43
▸ MMP1 P03956 3/20 0.43
▸ MMP9 P14780 3/20 0.43
▸ HTR6 P50406 3/20 0.40
▸ ADAM17 P78536 1/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ BCHE P06276 2/20 0.37
▸ MMP3 P08254 1/20 0.37
▸ MMP7 P09237 1/20 0.37
▸ ACKR3 P25106 1/20 0.36
▸ APLNR P35414 1/20 0.36
▸ ALOX5AP P20292 2/20 0.35
▸ FEN1 P39748 2/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ FAAH O00519 1/20 0.35
▸ JAK2 O60674 1/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23795403 1.00 MMP13 (0.43) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL24178165 1.00 MMP13 (0.43) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL24177988 0.90 MMP13 (0.41) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL23795385 0.90 MMP13 (0.41) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL23795420 0.89 MMP13 (0.45) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL23810437 0.89 MMP13 (0.45) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL30439166 0.83 MMP1 (0.47) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL24177901 0.82 HTR6 (0.39) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL23795379 0.82 HTR6 (0.39) MMP13MMP1MMP9HTR6ADAM17
SCHEMBL23810433 0.81 HTR6 (0.38) MMP13MMP1MMP9HTR6ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116555-B Rho kinase inhibitor and preparation method and application thereof 北京盈科瑞创新药物研究有限公司 2023-06-02 — — CN disclosed
Send feedback